- Report
- August 2025
- 187 Pages
Global
From €3496EUR$3,939USD£3,009GBP
- Report
- August 2025
- 190 Pages
Global
From €3496EUR$3,939USD£3,009GBP
- Report
- August 2025
- 182 Pages
Global
From €3147EUR$3,545USD£2,708GBP
€3496EUR$3,939USD£3,009GBP
- Report
- August 2025
- 182 Pages
Global
From €3147EUR$3,545USD£2,708GBP
€3496EUR$3,939USD£3,009GBP
- Report
- March 2025
- 250 Pages
Global
From €3985EUR$4,490USD£3,430GBP
- Report
- August 2025
- 378 Pages
Global
From €5193EUR$5,850USD£4,469GBP
- Clinical Trials
- July 2025
- 80 Pages
Global
From €1775EUR$2,000USD£1,528GBP
- Clinical Trials
- July 2025
- 60 Pages
Global
From €1110EUR$1,250USD£955GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1775EUR$2,000USD£1,528GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1775EUR$2,000USD£1,528GBP
- Report
- October 2024
- 160 Pages
Global
From €7057EUR$7,950USD£6,073GBP
- Report
- May 2025
- 169 Pages
Global
From €4216EUR$4,750USD£3,629GBP
- Report
- June 2025
- 200 Pages
Global
From €2476EUR$2,789USD£2,131GBP
- Newsletter
- August 2025
Global
€2658EUR$2,995USD£2,288GBP
- Report
- April 2022
- 400 Pages
Global
€1553EUR$1,750USD£1,337GBP
- Report
- May 2024
- 133 Pages
Global
From €5769EUR$6,499USD£4,965GBP
- Report
- May 2024
- 134 Pages
Global
From €5769EUR$6,499USD£4,965GBP
- Report
- August 2019
- 30 Pages
China
From €1953EUR$2,200USD£1,681GBP
- Report
- October 2023
- 71 Pages
India
From €3107EUR$3,500USD£2,674GBP
- Report
- December 2022
- 114 Pages
Global
From €3107EUR$3,500USD£2,674GBP

Edema is a medical condition characterized by the accumulation of fluid in the body's tissues. It is a common symptom of many diseases and can be caused by a variety of factors, including trauma, infection, and inflammation. In the biotechnology market, edema is a major area of research and development, with a focus on developing treatments and therapies to reduce the symptoms and improve the quality of life of those affected.
The biotechnology market for edema is highly competitive, with a range of companies developing treatments and therapies to address the condition. These include pharmaceutical companies, biotechnology companies, and medical device companies. Examples of companies in this market include AbbVie, Amgen, AstraZeneca, Biogen, and Novartis. Show Less Read more